US Patent Issued to Memorial Sloan Kettering Cancer Center, Cornell University on Jan. 27 for "Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy" (New York Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,428, issued on Jan. 27, was assigned to Memorial Sloan Kettering Cancer Center (New York) and Cornell University (Ithaca, N.Y.).

"Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy" was invented by Nai-Kong V. Cheung (New York), Steven M. Larson (New York), Sarah Cheal (New York), Richard Ting (Ithaca, N.Y.), Hari Krishna Kommidi (Ithaca, N.Y.), Feifei An (Ithaca, N.Y.) and Brian Santich (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods for the detection, and treatment of cancer. Specifically, the compositions of the pre...